This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / SCAN Identified as Parkinson's Disease Driver
Tech medical breakthrough

SCAN Identified as Parkinson's Disease Driver

Analysis based on 11 articles · First reported Feb 04, 2026 · Last updated Feb 09, 2026

Sentiment
70
Attention
6
Articles
11
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

This medical breakthrough redefines Parkinson s disease, potentially leading to new non-invasive treatments that could slow or reverse its progression. This could significantly impact the biotechnology and pharmaceutical sectors, creating new market opportunities for companies like Turing Medical.

Biotechnology Pharmaceuticals Medical Devices
Event Summary

An international research team, led by Changping Laboratory and Washington University in St. Louis, has identified the somato-cognitive action network (SCAN) as a central driver of Parkinson s disease. The study, published in Nature (journal), reveals that Parkinson s disease is characterized by excessive connectivity between the SCAN and the subcortex, disrupting movement and cognitive functions. Targeting the SCAN with non-invasive transcranial magnetic stimulation (TMS) showed a 2.5-fold increase in effectiveness in a clinical trial. This discovery challenges long-standing views of Parkinson s disease and points towards a new era of precise and targeted treatment approaches that could potentially slow or reverse the disease's progression. Nico Dosenbach, a co-author, plans clinical trials with his startup Turing Medical to further develop these non-invasive therapies.

Key Actions
95 Nico Dosenbach co-authored study and co-founded startup Turing Medical
85 Hesheng Liu senior author of study and chief scientist Neural Galaxy Inc.
70 Turing Medical plans to launch clinical trials
40 Nature (journal) published research findings
Entities Involved
per
Nico Dosenbach
Nico Dosenbach, a professor at Washington University in St. Louis, is a co-author of the study and previously described the SCAN. He is also co-founder of Turing Medical, which plans to launch clinical trials based on these findings, indicating significant personal and professional impact.
Importance 90 Sentiment 80
per
Hesheng Liu
Hesheng Liu is the senior author of the study and chief scientist of Neural Galaxy Inc. His work was crucial in analyzing brain imaging data and identifying the hyperconnectivity in Parkinson s disease, significantly advancing the understanding of the disease.
Importance 85 Sentiment 70
priv
Turing Medical
Turing Medical, a startup co-founded by Nico Dosenbach, plans to launch clinical trials for a non-invasive therapy based on the SCAN research. This positions Turing Medical to potentially develop and commercialize a new treatment for Parkinson s disease.
Importance 70 Sentiment 75
priv
Nature (journal)
Nature (journal) published the findings, lending significant credibility and visibility to the research. This publication reinforces its status as a leading scientific journal.
Importance 40 Sentiment 50
priv
Neural Galaxy Inc.
Hesheng Liu, the senior author of the study, is the chief scientist of Neural Galaxy Inc. This association could bring positive attention and potential opportunities to the company.
Importance 30 Sentiment 60
cnt
United States
The United States is one of the countries where brain imaging data was collected and where Parkinson s disease affects over 1 million people, highlighting the global relevance of the research.
Importance 10 Sentiment 0
cnt
China
China, through Changping Laboratory, led the international research team and contributed brain imaging data, showcasing its growing role in advanced medical research.
Importance 10 Sentiment 0
Relationships
Nico Dosenbach related ↔ Turing Medical
Hesheng Liu related ↔ Neural Galaxy Inc.
Nico Dosenbach related ↔ Hesheng Liu
Hesheng Liu related ↔ Turing Medical
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.